But how is it possible to be a true venture capital fund that delivers venture-level returns as well as social good? It depends on how you measure social impact.
We believe the secret is with an evolving healthcare paradigm enabled by data usage; explosive growth in volumes of data created by individuals are now fueling sustainable digital health strategies. Incredibly, over 90% of the world’s data was generated in just the last two years. Stop and think about that.
Brenda Irwin is the founder and general partner of Relentless Venture Fund, a Vancouver, British Columbia, Canada based early-stage fund investing in preventative health and proactive technology solutions. Irwin’s fund was one of the ten female founded venture capital funds I highlighted in an earlier post. In the earlier post Irwin offered up three network building solutions that she regularly puts to use:
This Vancouver, B.C. based venture fund invests at early-stage, seed and Series A in preventative and proactive health startups. Managing partner and co-founder Brenda Irwin, offers these network-building suggestions to achieve your venture goals:
The Relentless Venture Fund ("RVF") is a health technology venture capital fund dedicated to investing in preventative and proactive technology solutions that optimize health, activity and longevity.
Relentless is an early stage investor, investing in seed and Series A investments, and the company's mission is to invest in technology based businesses that contribute to active, healthy living at all ages.
Relentless Venture Fund (RVF), a health technology venture capital fund managed by Relentless Pursuit Partners, has secured a founding investment from Vancity, a Canadian community credit union. Terms weren’t disclosed.
Brenda Irwin is a managing partner at Relentless Pursuit Partners, a venture team that invests in preventative healthcare and technology companies that impact health and activity. She is extremely passionate about health, so much so that she braved one of Vancouver’s notorious rainstorms to ride her bike to this interview. Brenda has a lengthy and impressive portfolio in a range of market sectors, including drug development, biotech, medtech, digital health, wellness organizations and even 3D printing of biomaterials. She has also been a board director for 15 private and public for profit life sciences and biotechnology corporations.